Medical Health & Life Science Research News

New study: Global biodegradable stents market to reach $3.51 billion by 2022

The prevailing usage of stents in treatment of artery disease is rapidly providing market growth.

- Advertising -

According to Stratistics MRC, the Global Biodegradable Stents market is accounted for $0.47 billion in 2016 and is expected to reach $3.51 billion by 2022 growing at a CAGR of 39.8% during the forecast period 2016 to 2022. 

Patients demand for minimal invasive surgeries, growing geriatric population and technological advancements are some of the factors driving market. However, safety & regulatory issues and cost issues are some reasons behind the market lag.

- Advertising -

Browse the report: www.orbisresearch.com/reports/index/biodegradable-stents-global-market-outlook-2016-2022

Hospitals segment is expected to dominate the market, it is because of majority hospitals procuring medical products and consumables in bulk. Moreover, coronary artery disease is expected to dominate application segment on account of growing geriatric population and rising consequences of disease occurring.

In geographical segment, North America is estimated to dominate the market due to high prevalence of cardiovascular diseases. In addition to that, Asia Pacific market is expected to grow at highest CAGR attributing to growing awareness about Bioabsorbable stents.

Some of the key players of the Biodegradable Stents market include Abbott Laboratories, Amaranth Medical, Inc., Arterial Remodeling Technologies SA, Arterius Limited, BIOTRONIK SE & Co. KG, Biotronik, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., Meril Life Sciences, REVA Medical, Inc., SMT (Part of Sahajanand Group of Companies), Tepha, Inc. and Xenogenics Corporation.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/296659

End-Users Covered:
Cardiac Centers
Hospitals

Applications covered:
Coronary Artery Disease
Peripheral Artery Disease

Materials covered:
Metallic Stents
Polymeric Stents

Drugs covered:
Limus-Based Drugs
Paclitaxel

Absorption Rates covered:
Slow-Absorption Stents
Fast-Absorption Stents

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of APAC
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

News From

Orbis Research - Rendering Conscientious ResearchOrbis Research
Category: Market Research Publishers and RetailersCompany profile: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...